Transcription of Transcranial Magnetic Stimulation - UHCprovider.com
{{id}} {{{paragraph}}}
Transcranial Magnetic Stimulation Page 1 of 5 UnitedHealthcare Medicare Advantage Policy Guideline Approved 03/10/2021 Proprietary Information of UnitedHealthcare. Copyright 2021 United HealthCare Services, Inc. UnitedHealthcare Medicare Advantage Policy Guideline Transcranial Magnetic Stimulation Guideline Number: Approval Date: March 10, 2021 Terms and Conditions Table of Contents Page Policy Summary .. 1 Applicable Codes .. 2 Definitions .. 2 References .. 3 Guideline History/Revision Information .. 4 Purpose .. 4 Terms and Conditions .. 4 Policy Summary See Purpose Overview Transcranial Magnetic Stimulation (TMS) is a non-invasive, non-systemic treatment that uses Magnetic Resonance Imaging (MRI)-strength, pulsed, Magnetic fields to induce an electric current in a localized region of the cerebral cortex. An electromagnetic coil is placed on the scalp that induces a focal current in the brain and temporary modulation of cerebral cortical function.
Health Questionnaire Depression Scale (PHQ-9), the Beck Depression Scale (BDI) Hamilton Rating Scale for Depression (HAM-D), the Montgomery Asberg Depression Rating Scale (MADRS), the Quick Inventory of Depressive Symptomatology (QIDS) or
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}